Leaflet FUROAT DE MOMETAZONA AMRING 50mcg / dose nasal spray, suspension

Indicated for: allergic rhinitis; inflammatory dermatoses; asthma

Route of administration: nasal

Substance: mometasone (glucocorticoid)

ATC: R01AD09 (Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Mometasone is a corticosteroid used to treat inflammation and allergies, available as a nasal spray, cream, ointment, or inhaler. It is indicated for managing seasonal or perennial allergic rhinitis, nasal polyps, bronchial asthma, and inflammatory skin conditions such as atopic dermatitis or psoriasis.

It works by reducing inflammation, itching, and swelling, providing rapid symptom relief. For allergic rhinitis, mometasone helps reduce nasal congestion, sneezing, and nasal discharge.

It is generally well-tolerated but may cause side effects such as local irritation, nasal dryness, headaches, or, more rarely, nosebleeds. Long-term use requires medical monitoring to prevent systemic side effects.

Mometasone should be used as directed by a doctor, and patients should not exceed the recommended dose. It is an effective treatment for allergic and inflammatory symptoms but is not suitable for viral or bacterial infections.

General data about FUROAT DE MOMETAZONA AMRING 50mcg / dose

  • Substance: mometasone
  • Date of latest medicines list: 01-06-2026
  • Product code: W66244001
  • Concentration: 50mcg / dose
  • Pharmaceutical form: nasal spray, suspension
  • Quantity: 1
  • Product type: Generic medicine
  • Price: 29.68 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA
  • Holder: AMRING FARMA S.R.L. - ROMANIA
  • Number: 14283/2022/01
  • Shelf life: 2 years-after packaging for sale;after the first opening of the bottle- 2 months

Concentrations available for mometasone

  • 1mg/g
  • 200mcg/dose
  • 400mcg/dose
  • 50mcg/dose

Compensation lists for FUROAT DE MOMETAZONA AMRING 50mcg / dose Amring Farma

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

29.68 RON

9.89 RON

19.79 RON